Cargando…
A data mining approach for identifying pathway-gene biomarkers for predicting clinical outcome: A case study of erlotinib and sorafenib
A novel data mining procedure is proposed for identifying potential pathway-gene biomarkers from preclinical drug sensitivity data for predicting clinical responses to erlotinib or sorafenib. The analysis applies linear ridge regression modeling to generate a small (N~1000) set of baseline gene expr...
Autor principal: | Covell, David G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549706/ https://www.ncbi.nlm.nih.gov/pubmed/28792525 http://dx.doi.org/10.1371/journal.pone.0181991 |
Ejemplares similares
-
Development of a Drug-Response Modeling Framework to Identify Cell Line Derived Translational Biomarkers That Can Predict Treatment Outcome to Erlotinib or Sorafenib
por: Li, Bin, et al.
Publicado: (2015) -
Data Mining Approaches for Genomic Biomarker Development: Applications Using Drug Screening Data from the Cancer Genome Project and the Cancer Cell Line Encyclopedia
por: Covell, David G.
Publicado: (2015) -
Phase II trial of sorafenib and erlotinib in advanced pancreatic cancer
por: Cardin, Dana B, et al.
Publicado: (2014) -
Novel data-mining approach identifies biomarkers for diagnosis of Kawasaki disease
por: Tremoulet, Adriana H., et al.
Publicado: (2015) -
Integrating Constitutive Gene Expression and Chemoactivity: Mining the NCI60 Anticancer Screen
por: Covell, David G.
Publicado: (2012)